Dec 20 (Reuters) - Acasti Pharma Inc ACST.V :
* ACASTI PHARMA ACHIEVES PLANNED ENROLLMENT TARGETS FOR TRILOGY PHASE 3 TRIALS OF CAPRE® IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA
* ACASTI PHARMA INC - REMAIN CONFIDENT TO COMPLETE STUDIES ON SCHEDULE, EXPECT TO REPORT TOPLINE RESULTS BEFORE END OF CALENDAR 2019